ThinkTrends Lands $49 Million IDIQ Contract from the U.S. Food and Drug Administration for AI and Data Implementation SupportHERNDON, VA / ACCESS Newswire / October 14, 2026 / ThinkTrends, LLC has been awarded a five-year, $49 million single-award IDIQ contract by the U.S. Food and Drug Administration (FDA) to provide software implementation and support services across agency operations. The contract, awarded under a Total Small Business Set-Aside, was competed among eight offerors and issued under the Department of Health and Human Services.
ThinkTrends Agentic AI Goes Live With the U.S. Food and Drug Administration’s Nationwide Adverse Event Monitoring System
ThinkTrends agentic Document AI platform has been deployed at the U.S. Food and Drug Administration (FDA) as part of its new nationwide Adverse Event Monitoring System (AEMS), a major modernization initiative to improve how safety signals across drugs, vaccines, cosmetics, foods, medical devices, and other regulated products are monitored. The new platform replaces multiple fragmented reporting systems with a single real-time monitoring environment designed to process millions of adverse event reports each year across the agency’s product centers.
ThinkTrends Agentic AI Goes Live with U.S. Federal Health Agency’s Nationwide Adverse Event Monitoring System
ThinkTrends agentic Document AI platform has been deployed at the U.S. Federal Health Agency as part of its new nationwide Adverse Event Monitoring System (AEMS), a major modernization initiative to improve how safety signals across drugs, vaccines, cosmetics, foods, medical devices, and other regulated products are monitored. The new platform replaces multiple fragmented reporting systems with a single real-time monitoring environment designed to process millions of adverse event reports each year across the agency’s product centers.
